Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592709 · ClinicalTrials.gov registry record
Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry
A clinical trial of Brain Diseases, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 84
- Enrollment target
- 1
- Study location
NCT00592709: Completed study of Brain Diseases, sponsored by Vanderbilt University Medical Center.
NCT00592709 is a study of Brain Diseases that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 84 participants, below the 6,011-participant average among 12 other Brain Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592709, a study of Brain Diseases, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
We are collecting brain tissue specimens and blood samples from patients at Vanderbilt University Medical Center who are undergoing intracranial surgery to remove brain tissue, including brain tumors, tissue from epilepsy surgery and brain tissue removed during surgery for other non-cancerous types of brain tissus. These specimens will then be studied using a novel microscopic laser-directed protein mass spectrometric analysis, looking for unique protein signatures.
Primary Outcome
measurement of proteomic signatures in brain tumor samples for unique protein signatures
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center, Department of Neurological Surgery - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2003-05 |
| Est. Completion | 2012-12 |
What the finished NCT00592709 record still lists
NCT00592709 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 6,011-participant average among 12 other Brain Diseases trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Brain Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT00592709 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00592709 about?
NCT00592709 is a clinical study titled "Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry". We are collecting brain tissue specimens and blood samples from patients at Vanderbilt University Medical Center who are undergoing intracranial surgery to remove brain tissue, including brain tumors, tissue from epilepsy surgery and brain tissue removed during surgery for other non-cancerous types ...
What is the current status of trial NCT00592709?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2003-05. Estimated completion is 2012-12.
What conditions does trial NCT00592709 study?
This clinical trial studies the following conditions: Brain Diseases.
Who is sponsoring clinical trial NCT00592709?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00592709 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00592709's enrollment target sits among peer trials
84 8th of 12 higher than 5 of 12 other Brain Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RECRUITING · Phase 1
-
Amygdala Memory Enhancement
RECRUITING · NA
-
University of Central Florida CereBank
RECRUITING
-
Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
RECRUITING · NA
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
RECRUITING · NA
-
Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia